QUEBEC CITY and MYRTLE BEACH, SC, Sept. 25, 2017 /PRNewswire/ - TSO3 Inc. (TSX:TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that Dr. Bradley J. Catalone MBA, Ph.D. has joined TSO3 as its Chief Science Officer.
"I am very pleased to welcome Brad to the TSO3 organization" stated R.M. (Ric) Rumble TSO3's President and CEO. "Brad brings fifteen years of professional experience with increased accountability and responsibility within our industry. He is a strong advocate for patient safety and has directly championed improvements in device reprocessing."
As Chief Science Officer, Dr. Catalone will oversee all scientific operations to ensure completion of key development milestones and targeted projects. Dr. Catalone will be responsible of relationships with external stakeholders, including regulatory agencies, leading scientific institutions and standard-setting organizations.
Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
For more information about TSO3, visit the Company's website at www.tso3.com.
SOURCE TSO3 Inc.
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All